Altimmune (ALT) Stock: Buy, Sell, or Hold?
ALT - Altimmune, Inc. Common Stock
$2.17
-0.06 (-2.69%)
▼
5d:
-8.05%
30d:
-31.97%
90d:
-21.66%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 05, 2026
12d
Get Alerted When ALT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ALT shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ALT shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: ALT is currently trading at $2.17, which is considered oversold relative to its 30-day fair value range of $2.39 to $3.16.
Technical Outlook: Technically, ALT is in a strong downtrend. The price is currently testing key support at $2.15. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ALT scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $17.11 (+688.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ALT is in a strong downtrend. The price is currently testing key support at $2.15. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ALT scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $17.11 (+688.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.39 -
$3.16
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 688.5% below Wall St target ($17.11)
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.39 -
$3.16
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.15
Resistance Level
$2.64
Current Trend
Strong Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.25
Wall Street Target
$17.11
(+688.5%)
Revenue Growth (YoY)
420.0%
Share & Embed Analysis
Last updated: October 23, 2026 6:48 AM ET
Data refreshes hourly during market hours. Next update: 7:48 AM
Data refreshes hourly during market hours. Next update: 7:48 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
20 analysts |
$650 | 61 BUY |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
17 analysts |
$36 | 57 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 66 BUY |
|
ELVN
Enliven Therapeutics Inc. |
STRONG BUY
14 analysts |
$74 | 60 BUY |
|
IMUX
Immunic Inc |
STRONG BUY
12 analysts |
$43 | 68 BUY |
